Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR)

Historical Holders from Q1 2021 to Q2 2025

Symbol
VOR on Nasdaq
CUSIP
929033108
Type / Class
Equity / Common Stock, par value $.0001 per share
Shares outstanding
6.84M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
57M
Holdings value
$91.8M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
33
Number of buys
15
Number of sells
-29
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 31.8% -0.31% $5.96M $4.5K 39.7M +0.08% RA Capital Management, L.P. Jun 25, 2025
5AM Ventures VI, L.P. 3.5% $663K 4.42M Andrew J. Schwab Jul 8, 2025
FMR LLC 1.7% -68% $314K -$649K 2.09M -67.4% FMR LLC Jun 30, 2025
Reprogrammed Interchange LLC 21.9% -6.09% $2.73M -$179K 1.5M -6.16% Reprogrammed Interchange LLC Oct 6, 2025

Institutional Holders of Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 57M $91.8M -$3.75M $1.62 33
2025 Q1 60.1M $43.1M -$1.21M $0.72 44
2024 Q4 60.9M $67.6M +$16.1M $1.11 51
2024 Q3 47.8M $33.5M -$6.82M $0.70 53
2024 Q2 54.5M $54.5M -$7.86M $1.00 67
2024 Q1 58.9M $140M -$1.22M $2.37 67
2023 Q4 15.9K $35.8K $2.25 1
2023 Q3 60.2M $128M -$1.55M $2.12 59
2023 Q2 60.8M $188M -$4.65M $3.09 70
2023 Q1 60.5M $326M +$1.56M $5.38 60
2022 Q4 60.2M $400M +$191M $6.65 58
2022 Q3 31.5M $125M +$1.52M $3.98 42
2022 Q2 31.1M $155M +$351K $4.97 43
2022 Q1 31M $187M -$1.51M $6.04 50
2021 Q4 31.1M $362M -$5.7M $11.62 57
2021 Q3 27.5M $431M +$3.13M $15.68 50
2021 Q2 30.8M $571M -$547K $18.65 51
2021 Q1 30.7M $1.31B +$1.31B $43.10 49